3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure

Details for Australian Patent Application No. 2004245492 (hide)

Owner Allergan, Inc.

Inventors Dinh, Thang D.; Burk, Robert M.; Old, David W.

Agent Davies Collison Cave

Pub. Number AU-B-2004245492

PCT Pub. Number WO2004/108670

Priority 10/453,207 02.06.03 US

Filing date 25 May 2004

Wipo publication date 16 December 2004

Acceptance publication date 19 August 2010

International Classifications

C07D 207/26 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/108670 Priority application(s): WO2004/108670

19 August 2010 Application Accepted

  Published as AU-B-2004245492

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245513-Superfinishing large planetary gear systems

2004245490-8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents